In order to identify whether polymorphisms of OCT1 and OCT2 contribute to the variability in PCOS itself and treatment response, a prospective study was conducted in which 150 PCOS patients of European descent were treated with metformin [24]. This evidence concerns the gene POU2F1 and polycystic ovary syndrome.